Ardent Health Statistics
Total Valuation
Ardent Health has a market cap or net worth of $1.51 billion. The enterprise value is $3.06 billion.
| Market Cap | 1.51B |
| Enterprise Value | 3.06B |
Important Dates
The last earnings date was Tuesday, August 4, 2026, after market close.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Ardent Health has 141.05 million shares outstanding. The number of shares has increased by 1.33% in one year.
| Current Share Class | 141.05M |
| Shares Outstanding | 141.05M |
| Shares Change (YoY) | +1.33% |
| Shares Change (QoQ) | +0.90% |
| Owned by Insiders (%) | 1.67% |
| Owned by Institutions (%) | 21.93% |
| Float | 52.10M |
Valuation Ratios
The trailing PE ratio is 19.90 and the forward PE ratio is 9.97. Ardent Health's PEG ratio is 2.69.
| PE Ratio | 19.90 |
| Forward PE | 9.97 |
| PS Ratio | 0.24 |
| Forward PS | 0.23 |
| PB Ratio | 1.15 |
| P/TBV Ratio | 4.02 |
| P/FCF Ratio | 5.06 |
| P/OCF Ratio | 3.00 |
| PEG Ratio | 2.69 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.30, with an EV/FCF ratio of 10.12.
| EV / Earnings | 39.43 |
| EV / Sales | 0.48 |
| EV / EBITDA | 7.30 |
| EV / EBIT | 11.96 |
| EV / FCF | 10.12 |
Financial Position
The company has a current ratio of 2.10, with a Debt / Equity ratio of 1.30.
| Current Ratio | 2.10 |
| Quick Ratio | 1.49 |
| Debt / Equity | 1.30 |
| Debt / EBITDA | 3.31 |
| Debt / FCF | 7.44 |
| Interest Coverage | 5.05 |
Financial Efficiency
Return on equity (ROE) is 9.96% and return on invested capital (ROIC) is 6.25%.
| Return on Equity (ROE) | 9.96% |
| Return on Assets (ROA) | 3.13% |
| Return on Invested Capital (ROIC) | 6.25% |
| Return on Capital Employed (ROCE) | 5.99% |
| Weighted Average Cost of Capital (WACC) | 4.36% |
| Revenue Per Employee | $254,204 |
| Profits Per Employee | $3,104 |
| Employee Count | 25,200 |
| Asset Turnover | 1.24 |
| Inventory Turnover | 22.74 |
Taxes
In the past 12 months, Ardent Health has paid $39.32 million in taxes.
| Income Tax | 39.32M |
| Effective Tax Rate | 18.91% |
Stock Price Statistics
The stock price has decreased by -13.39% in the last 52 weeks. The beta is 0.70, so Ardent Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | -13.39% |
| 50-Day Moving Average | 10.29 |
| 200-Day Moving Average | 9.65 |
| Relative Strength Index (RSI) | 53.98 |
| Average Volume (20 Days) | 468,805 |
Short Selling Information
The latest short interest is 4.32 million, so 3.06% of the outstanding shares have been sold short.
| Short Interest | 4.32M |
| Short Previous Month | 4.49M |
| Short % of Shares Out | 3.06% |
| Short % of Float | 8.29% |
| Short Ratio (days to cover) | 7.96 |
Income Statement
In the last 12 months, Ardent Health had revenue of $6.41 billion and earned $78.23 million in profits. Earnings per share was $0.55.
| Revenue | 6.41B |
| Gross Profit | 3.74B |
| Operating Income | 257.90M |
| Pretax Income | 207.96M |
| Net Income | 78.23M |
| EBITDA | 422.42M |
| EBIT | 257.90M |
| Earnings Per Share (EPS) | $0.55 |
Balance Sheet
The company has $724.48 million in cash and $2.27 billion in debt, with a net cash position of -$1.54 billion or -$10.94 per share.
| Cash & Cash Equivalents | 724.48M |
| Total Debt | 2.27B |
| Net Cash | -1.54B |
| Net Cash Per Share | -$10.94 |
| Equity (Book Value) | 1.74B |
| Book Value Per Share | 9.52 |
| Working Capital | 1.08B |
Cash Flow
In the last 12 months, operating cash flow was $514.32 million and capital expenditures -$209.57 million, giving a free cash flow of $304.76 million.
| Operating Cash Flow | 514.32M |
| Capital Expenditures | -209.57M |
| Depreciation & Amortization | 164.52M |
| Net Borrowing | -7.05M |
| Free Cash Flow | 304.76M |
| FCF Per Share | $2.16 |
Margins
Gross margin is 58.38%, with operating and profit margins of 4.03% and 1.22%.
| Gross Margin | 58.38% |
| Operating Margin | 4.03% |
| Pretax Margin | 3.25% |
| Profit Margin | 1.22% |
| EBITDA Margin | 6.59% |
| EBIT Margin | 4.03% |
| FCF Margin | 4.76% |
Dividends & Yields
Ardent Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.33% |
| Shareholder Yield | -1.33% |
| Earnings Yield | 5.07% |
| FCF Yield | 19.77% |
Analyst Forecast
The average price target for Ardent Health is $12.68, which is 18.06% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.68 |
| Price Target Difference | 18.06% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 3.59% |
| EPS Growth Forecast (3Y) | -7.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ardent Health has an Altman Z-Score of 2.03 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.03 |
| Piotroski F-Score | 6 |